Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades

The development of immune checkpoint blockade (ICB)-based immunotherapy has dramatically changed methods of cancer treatment. This approach triggers a durable treatment response and prolongs patients' survival; however, not all patients can benefit. Accumulating evidence demonstrated that the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jun-Yan, Chen, Yu-Pei, Li, Ying-Qin, Liu, Na, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863268/
https://www.ncbi.nlm.nih.gov/pubmed/33541368
http://dx.doi.org/10.1186/s12943-021-01317-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863268/
https://www.ncbi.nlm.nih.gov/pubmed/33541368
http://dx.doi.org/10.1186/s12943-021-01317-7

Ejemplares similares